Evaluation of the CMS Quality Improvement Organizations: Medication Safety and Adverse Drug Event Prevention (CMS-10675)

Sections 1152-1154 of the Social Security Act requires the Centers for Medicare & Medicaid Services (CMS) to direct the Quality Improvement Organization (QIO) Program, one of the largest federal programs dedicated to improving healthcare quality for Medicare beneficiaries. QIOs help Medicare providers with quality improvement throughout the spectrum of care and review quality concerns for the protection of beneficiaries and the Medicare Trust Fund. This program is a key component of the U.S. Department of Health and Human Services' National Quality Strategy and the CMS Quality Strategy, with the overarching goals to achieve better healthcare, better health and lower costs of care. The purpose of this Information Collection Request (ICR) is to conduct a survey to inform the evaluation of one of the tasks of the QIO Program’s 11th Scope of Work (SOW). This ICR focuses on data collection to assess Task C.3-6 Increasing Medication Safety and Preventing Adverse Drug Events. The survey will be completed by prescribers, pharmacists and nursing home administrators/directors of nursing who are participating in the QIO program and those not involved with the QIO program in order to evaluate the effect of the QIO program on quality improvement efforts in community settings.

The latest form for Evaluation of the CMS Quality Improvement Organizations: Medication Safety and Adverse Drug Event Prevention (CMS-10675) expires 2022-02-28 and can be found here.